Gattefossé S.A.
Premium PartnerIs this your company? Claim this profile
Excipients & Specialty Ingredients
Regulatory, Tech Transfer & Support Services
Company Overview
About
Gattefossé S.A. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:China
Founded:2000
Employees:1,841
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval JI39RA
EMA · #APR-BZPLE2NM · 2019-10-01
Certifications
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-HH9KQR9S
Issued: 2020-03-27
Expires: 2025-10-11
WHO GMP
World Health Organization
Cert #: CERT-URBSVYAD
Issued: 2020-11-05
Expires: 2025-04-09
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-SYGYLXYA
Issued: 2020-11-23
Expires: 2025-08-24
Health Canada GMP
Health Canada
Cert #: CERT-T14P8BMS
Issued: 2020-02-25
Expires: 2025-02-01
Loading CDMO intelligence...
Key facts about Gattefossé S.A.
- Gattefossé S.A. is headquartered in China.
- Gattefossé S.A. was founded in 2000.
- Gattefossé S.A. has 1,841 employees.
- Gattefossé S.A.'s capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Gattefossé S.A.
Directory pages this company appears in, each with the full list of matching manufacturers.